Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

North America Clinical Trials Market Outlook

The North America clinical trials market size was valued at USD 35.31 billion in 2023. The market is further projected to grow at a CAGR of 6.0% between 2024 and 2032, reaching a value of USD 60.16 billion by 2032.

Key Takeaways

  • The Canadian pharmaceutical sector leads in clinical trial initiation in the country, especially in trials for drugs for rare diseases and oncology products.
  • In 2022, the United States accounted for 18.4% of the global clinical trial activity. 
  • In 2021, Canada accounted for a 3.8% share of the global clinical trials activity. 

According to the North America clinical trials market analysis, clinical trials are a crucial testing ground for potential drugs and devices. The advancing technological landscape in the healthcare sector has enhanced the way life science companies conduct clinical trials. Technologies, such as artificial intelligence, decentralised clinical trials, and wearable devices help companies conducting clinical trials overcome common challenges of the market, such as poor study design, ineffective site selection, and participant dropout. 

A strong regulatory framework in the field of clinical trials is also strengthening the North America clinical trials market development. For instance, Health Canada, the Federal department helping Canadians maintain and improve their health, is working on modernising the Canadian clinical trials’ regulatory framework. It proposes the establishment of a single authorisation of a trial involving multiple health products, the use of a risk-based approach for regulating clinical trials, and the approval of decentralised/hybrid trials to increase diversity and inclusion. In the United States, the Food and Drug Administration (FDA) sets rigorous standards for clinical trial design, collecting and analysing data, and reviewing all applications for new drug approvals.

Industry-sponsored trials are widely popular in North America. In 2022, these trials accounted for 63.9% share of all the clinical trials in the United States. Oncology was the leading therapeutic area for industry-sponsored clinical trials with a 37.0% share in the United States in 2022.

North America Clinical Trials Market

Market Segmentation

North America Clinical Trials Market Report and Forecast 2024-2032 offers a detailed analysis of the market based on the following segments.

Market Breakup by Service Type

  • Laboratory Service
  • Bioanalytical Testing Services
    • Cell-Based Assays
    • Virology Testing
    • Serology, Immunogenicity, and Neutralizing Antibodies
    • PK/PD Testing
    • Method Development, Optimisation, and Validation
    • Biomarker Testing
    • Others
  • Decentralized Clinical Trial Services
  • Patient Recruitment Services
  • Site Identification Services
  • Analytical Testing Services
  • Supply and Logistics Services
  • Protocol Designing Services
  • Data Management Services
  • Medical Device Testing Services
  • Others

Market Breakup by Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Market Breakup by Therapeutic Area

  • Oncology
  • Infectious Diseases
  • Neurology
  • Metabolic Disorders
  • Immunology
  • Cardiology
  • Genetic Diseases
  • Women’s Health
  • Others

Market Breakup by Application

  • Small Molecules
  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Others

Market Breakup by Country

  • United States of America
  • Canada

Competitive Landscape

The key players in the clinical trials market in North America are conducting trials in accordance with the stringent regulatory framework in the region.

  • IQVIA Inc
  • Laboratory Corporation of America Holdings
  • Syneos Health
  • Charles River Laboratories
  • Thermo Fisher Scientific Inc
  • Parexel International (MA) Corporation
  • Medpace, Inc.
  • ACM Global Laboratories
  • Frontage Labs
  • Dropoff, Inc.
  • Others

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Service Type
  • Phase
  • Therapeutic Area
  • Application
  • Region
Breakup by Service Type
  • Laboratory Service
  • Bioanalytical Testing Services
  • Decentralized Clinical Trial Services
  • Patient Recruitment Services
  • Site Identification Services
  • Analytical Testing Services
  • Supply and Logistics Services
  • Protocol Designing Services
  • Data Management Services
  • Medical Device Testing Services
  • Others
Breakup by Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Breakup by Therapeutic Area
  • Oncology
  • Infectious Diseases
  • Neurology
  • Metabolic Disorders
  • Immunology
  • Cardiology
  • Genetic Diseases
  • Women’s Heath
  • Others
Breakup by Application
  • Small Molecules
  • Monoclonal Antibodies
  • Vaccines
  • Cell and Gene Therapy
  • Others
Breakup by Region
  • United States of America
  • Canada
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • IQVIA Inc
  • Laboratory Corporation of America Holdings
  • Syneos Health
  • Charles River Laboratories.
  • Thermo Fisher Scientific Inc
  • Parexel International (MA) Corporation.
  • Medpace, Inc.
  • ACM Global Laboratories
  • Frontage Labs
  • Dropoff, Inc.
  • Others

North America Clinical Trials Market Report Snapshots

North America Clinical Trials Market Size

North America Clinical Trials Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

In 2023, the clinical trials market reached an approximate value of USD 35.31 billion.

The market is expected to grow at a CAGR of 6.0% between 2024 and 2032.

The market is estimated to witness healthy growth in the forecast period of 2024-2032 to reach USD 60.16 billion by 2032.

Clinical trials are research studies that test a behavioural, medical, or surgical intervention in people. Through these trials, researchers determine if a new form of treatment, drug, diet, or medical device is safe for people.

FDA oversees clinical trials to ensure conducted, analysed, and reported as per federal law and good clinical practice (GCP) regulations. FDA also ensures that the right, safety, and welfare of the people participating in the trial is protected.

The major drivers of the market include a strong regulatory framework, the advancement of technology in the clinical trials market, and the rising number of people suffering from cancer and infectious diseases.

Key trends aiding market expansion include extensive research and development to advance the clinical trial market, the integration of technologies such as artificial intelligence, and the rising number of diseases.

Major countries in the market are the United States of America and Canada.

The common phases of clinical trials are phase I, phase II, phase III, and phase IV.

Key players in the market are IQVIA Inc., Laboratory Corporation of America Holdings, Syneos Health, Charles River Laboratories, Thermo Fisher Scientific Inc., Parexel International (MA) Corporation, Medpace, Inc., ACM Global Laboratories, Frontage Labs, Dropoff, Inc., and others.

Purchase Full Report

Datasheet

 

USD 2,639

USD 2,299

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 4,399

USD 3,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 5,829

USD 4,899

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 6,929

USD 5,899

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63 287899028, +63 967 048 3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124